Enalapril Maleate Tablets, USP 20 mg
Rising Pharma is recalling Enalapril Maleate 20 mg tablets (NDC 64980-688-10) due to failed impurities test.
Do not use this medication. Contact your pharmacy or healthcare provider immediately to obtain a replacement or alternative medication. Return the affected bottle to your pharmacy for proper disposal.
Why it was recalled
Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test
How to identify it
Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai 400 030, India, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 64980-688-10.
Where it was sold
Distributed in US.
Official source
Editorial summary by Recall Canary · last updated 2026-05-06 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification